WEC
62
-3
ZTS
31
-7
AMP
64
10
DHI
31
3
APA
50
4
RSG
64
-4
CHD
42
-5
PPL
62
-2
FDX
51
3
FCX
57
10
XRAY
25
5
FMC
43
6
HCA
59
-9
NKE
30
-3
HUM
42
5
ADP
68
-9
ALLE
41
4
PAYX
59
-6
QRVO
64
3
EQT
45
-6
WEC
62
-3
ZTS
31
-7
AMP
64
10
DHI
31
3
APA
50
4
RSG
64
-4
CHD
42
-5
PPL
62
-2
FDX
51
3
FCX
57
10
XRAY
25
5
FMC
43
6
HCA
59
-9
NKE
30
-3
HUM
42
5
ADP
68
-9
ALLE
41
4
PAYX
59
-6
QRVO
64
3
EQT
45
-6
Financhill
Back

Immunovant Stock Predictions

Big exits started like this. So did Mode

Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/elite
Sell
20

IMVT
Immunovant

Last Price:
$16.60
Seasonality Move:
19.17%

7 Day Trial

ALL ACCESS PASS

$ 7

Sold-out (twice) tech raise for accredited investors only

Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/elite

Immunovant Stock Forecast

  • Over the next 52 weeks, Immunovant has on average historically risen by 44.5% based on the past 5 years of stock performance.
  • Immunovant has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
  • Is Immunovant Stock Undervalued?
    The current Immunovant [IMVT] share price is $16.29. The Score for IMVT is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • IMVT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Immunovant Stock Go Up Next Year?

  • Over the next 52 weeks, Immunovant has on average historically risen by 44.5% based on the past 5 years of stock performance.

Immunovant Stock Rating

Sell
20
Immunovant (IMVT) is a Sell

Is Immunovant overpriced?

  • Immunovant has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%

Immunovant Stock Price History

Is IMVT stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IMVT is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
immunovant.com

52-Week Data

52-Week High:
34.47
52-Week Low:
12.72

Prediction Charts

Market Cap:
2.8B
Price in USD:
16.29
Volume:
1.1M
Beta:
0.73

Technical Analysis

SMA50:
15.01
SMA100:
17.83
SMA200:
23.28
52-Wk Change:
-35.28%

Stock Predictions

  • Is Immunovant stock public?
    Yes, Immunovant is a publicly traded company.
  • What is the Immunovant stock quote today?
    The Immunovant stock price is 16.29 USD today.
  • How to buy Immunovant stock online?
    You can buy Immunovant shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-20 14.70 15.00 15.08 14.47
May-21 14.74 14.41 14.94 14.34
May-22 14.48 14.56 14.67 14.15
May-23 14.19 14.46 14.48 14.11
May-27 14.79 14.29 14.88 14.04
May-28 14.30 14.10 14.92 13.79
May-29 14.75 14.89 15.22 14.09
May-30 14.77 14.85 15.02 14.29
Jun-2 14.83 15.41 15.49 14.58
Jun-3 15.46 15.44 15.84 15.21
Jun-4 15.58 15.34 15.66 15.30
Jun-5 15.35 16.02 16.16 15.02
Jun-6 16.35 16.77 17.10 16.26
Jun-9 17.08 16.29 17.15 15.95

Immunovant Earnings

Immunovant Earnings Report: Per Share Immunovant Earnings Q1 Q2 Q3 and Q4 last year and next year.

Immunovant Forecast Revenue Growth

Immunovant Stock Analysis: Historical quarterly revenues per share for Immunovant and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.07 per share, a decrease this year of $1.13 per share, and an increase next year of $0.02 per share.

* Immunovant stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.